Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drug delivery systems – the helping hand for patients. The emergence of safer and patient-friendly devices is acting as a strong enabler for subcutaneous delivery of therapeutics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

pharmaphorum

MAY 21, 2021

Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate tirzepatide, setting up regulatory filings for a drug that the drugmaker thinks could be the lynchpin of its franchise in the coming years. . Treatment with Lilly’s drug also resulted in a 11.7 Arecor alliance.

Trials 52

Trials Insulin Sales Drug Delivery 52

Roots Analysis

FEBRUARY 22, 2022

Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient and relatively simple manner. Autoinjector As Emerging Drug Delivery Device.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

BioSpace

NOVEMBER 17, 2022

Editas Medicine is pausing its ocular gene therapy program after demonstrating a favorable safety profile and seeking a potential partner to develop EDIT-101, the company announced Thursday.

Gene Therapy 43

Gene Therapy Gene Gene Editing Medicine 43

Camargo

OCTOBER 14, 2020

ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD). Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. This closed-loop system is the first of its kind and portends future closed-loop systems for other diseases.

Development 196

Development Insulin Drug Delivery Production 196

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These medical devices are designed to administer drug subcutaneously. These devices have capability to hold and deliver precise dosages of drugs ranging from a few milliliters to several milliliters.

Drug Delivery 40

Drug Delivery Marketing Insulin Manufacturing 40

pharmaphorum

JUNE 10, 2021

Simply put, the revenues and profits from today’s mainstream drugs fund the scientific discovery that make tomorrow’s breakthrough drugs and critical vaccines possible. The truth about rising drug prices is more nuanced and merits exploration. The Big Misconception.

Manufacturing 105

Manufacturing Pharma Companies Drugs Pharmacy 105

FDA Law Blog

JANUARY 5, 2023

Combination products might be part drug, part device, or part software or hardware. One example is the Warning Letter FDA sent to Medtronic in late 2021 concerning a vulnerability in insulin infusion pumps. Combination products are sharing the digital moment with those classified solely as medical devices.

Regulation 59

Regulation Production Drug Delivery Marketing 59